PAM
KERX

Panagora Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Panagora Asset Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,751
Closed -$34K – 2615
2017
Q2 		$34K Buy
+4,751
New +$29.7K ﹤0.01% 2149
2015
Q2 		– Sell
-36,584
Closed -$466K – 2503
2015
Q1 		$466K Buy
+36,584
New +$470K ﹤0.01% 1345
2014
Q4 		– Sell
-1,401
Closed -$19K – 2387
2014
Q3 		$19K Sell
1,401
-1,790
-56% -$27.4K ﹤0.01% 2173
2014
Q2 		$49K Buy
3,191
+1,284
+67% +$18.2K ﹤0.01% 2105
2014
Q1 		$32K Buy
+1,907
New +$28.8K ﹤0.01% 2162

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Panagora Asset Management's KERX Position: Q3 2017 in Review

Panagora Asset Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2017, closing a stake of 4,751 shares — an estimated $34K sold.

Panagora Asset Management first reported a position in KERX in Q1 2014 and held it in 5 quarters. The position peaked at $466K in Q1 2015. 132 funds tracked by Wall St. Rank hold KERX as of Q3 2017.

  • Panagora Asset Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2017 after selling out during the quarter.
  • Panagora Asset Management sold 4,751 Keryx Biopharmaceuticals Inc shares in Q3 2017, an estimated $34K.
  • Panagora Asset Management first reported a position in Keryx Biopharmaceuticals Inc in Q1 2014 and held it in 5 quarters.
  • Panagora Asset Management's Keryx Biopharmaceuticals Inc position peaked at $466K in Q1 2015.
  • 132 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2017.

Based on Panagora Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.